awmsg logo



dequalinium chloride (Fluomizin®)


Reference No. 2775

Publication date:
21/11/2016


Appraisal information

dequalinium chloride (Fluomizin®) 10 mg vaginal tablet


Company: Kora Corporation Ltd trading as Kora Healthcare
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: 05/10/2016
AWMSG meeting date: 09/11/2016
   
   
Submission Type: Full Submission
Status: Recommended with restrictions
Advice No: 3416
Ministerial ratification: 18/11/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Dequalinium chloride (Fluomizin®) for the treatment of bacterial vaginosis is recommended as an option for restricted use within NHS Wales. Dequalinium chloride (Fluomizin®) for the treatment of bacterial vaginosis is restricted for use after initial treatment is ineffective or not tolerated as an alternative option to clindamycin vaginal cream. Dequalinium chloride (Fluomizin®) is not recommended for use within NHS Wales outside of this population.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download